Clinical Trials Browser

Phase 3 × Rectal Neoplasms × Rifaximin × Clear all

NCT01345175 2024-05-14

Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer

Phase 3 Completed

69 enrolled 9 charts

Gastrointestinal

Rectal Neoplasms